Mehalick David
CEO and President at Coeptis Therapeutics Inc.
- Sold, on record
- None
- Dollars the filings state
- Form 4 sales
- 1
- Latest Nov 16, 2021
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Coeptis Therapeutics Inc.CEO and President
Sales by reason
0
Routine
0
Plan not stated
0
No plan
1
Unusual
Form 4 sales per year, every sale on record.
Timeline
- 1 Form 4 sale Coeptis Therapeutics Inc.UnusualNov 16, 2021 2021
Sold 1.2M shares
Mehalick David, CEO and President
Sold 40% of holdings1.8M shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (1)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Nov 16, 2021 | Nov 18, 2021 | Coeptis Therapeutics Inc. | CEO and President | Form 4 sale | 1.2M | 40.0% | Unusual | SEC |